In addition, tryptophan showed an age-related decrease in both AD and Ctrl groups, and significant correlations with γ-GT, ALT, and FT4 in our study, which suggested that tryptophan may be a clinical marker of disease risk in the elderly. Here, GPT is linked to Alzheimer disease.